Pantothenate kinase associated neurodegeneration: Case series by Fotso, Vicky et al.
African Journal of Neurological Sciences               2020 - Vol. 39, No 1 
http://ajns.paans.org 
48 
CASE REPORT / CAS CLINIQUES 
PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION: CASE SERIES. 
 







EL MOUTAWAKIL Bouchra 
1
 
RAFAI Abdoh Mohamed 
1
 




1. Department of neurology-neurophysiology, IBN Rochd University Health Center, Casablanca. 
2. Regional Hospital Center, Moulay Youssef, Casablanca. Faculty of Medicine and Pharmacy of 
Casablanca, Morocco 
 
E-Mail Contact - FOTSO Vicky:fotso21@gmail.com 
Keywords: Eye of the tiger sign, NBIA, Oromandibular dystonia, PKAN. 




Neurodegeneration with brain iron accumulation (NBIA) encompasses a heterogeneous group of hereditary 
disorders characterized by iron deposition particularly in the basal ganglia. Pantothenate kinase‐associated 
neurodegeneration (PKAN) is the most common NBIA. PKAN, due to mutation in the PANK 2 gene has two main 
presentations. 
Case report:  
The classic form usually starts in the first decade of life with severe dystonia, dysarthria, parkinsonism, pyramidal, 
visual signs, and cognitive disturbances with an aggressive course, leading to death by the second decade of life. 
The atypical form is characterized by a slower progression, and a more benign course. A brain magnetic 
resonance imaging usually shows the eye of the tiger sign. Here, we report four cases whose age of onset and 
clinical presentation suggests typical form of PKAN. 
Conclusion:  
In sum, the data of our patients corroborated those of the classic form of PKAN. The perspective in this entity is 
the development of rational therapeutics targeting the primary biochemical anomaly, with compounds that bypass 
the defective PANK2 enzyme including phantasein, phosphopanthethein and coenzyme A.  
 
RESUME 
Introduction :  
La neurodégénérescence avec accumulation intracérebrale de fer (NBIA) constitue un groupe hétérogène de 
pathologies héréditaires caractérisées par un dépôt de fer en particulier dans les noyaux gris centraux. La 
neurodégénérescence associée à un déficit en Pantothenate kinase (PKAN) représente la forme la plus courante 
de NBIA. Elle est due à une mutation dans le gène PANK 2 et comporte 2 formes cliniques.  
Cas cliniques :  
La forme classique débute généralement au cours de la première décade par une dystonie sévère, une 
dysarthrie, un parkinsonisme, des signes pyramidaux, visuels et des troubles cognitifs d‘évolution sévère 
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entrainant la mort au cours de la deuxième décade. La forme atypique est caractérisée par une progression plus 
lente et une évolution plus bénigne. Une imagerie par résonance magnétique cérébrale montre généralement le 
signe des yeux de tigre. Nous rapportons ici quatre cas dont l‘âge d‘apparition et la présentation clinique 
suggèrent une forme typique de PKAN. 
Conclusion :  
En somme, les données de nos patients corroborent celles de la forme classique de PKAN. La perspective de 
cette entité est le développement de thérapies rationnelles ciblant l'anomalie biochimique primaire, avec des 




NBIA comprises a heterogeneous group of rare and hereditary disorders characterized by iron deposition 
particularly in the basal ganglia and sometimes in the substantia nigra and adjacent areas (2). The NBIA 
shares common clinical features including motor disorders, particularly parkinsonism and dystonia, cognitive 
dysfunction, pyramidal signs, and retinal abnormalities (2,4). PKAN, formerly called Hallervorden‐Spatz 
disease, due to mutations in the PANK2 gene is the most common NBIA (30-50% of NBIA cases) (2,5,7). It 
has 2 main presentations: The classic form usually starts in the first decade of life with severe dystonia, 
dysarthria, parkinsonism, pyramidal and visual signs, and less cognitive disturbances with an aggressive 
course, leading to death by the second decade of life (7). In the atypical form, neuropsychiatric disorders are 
common with a slower progression and a more benign course (2, 5). A brain magnetic resonance imaging 
(MRI) usually shows the eye of the tiger sign (5). Here, we describe four cases whose age of onset and 
clinical presentation suggests a typical form of PKAN. 
CASE SERIES 
Case 1 
This 17‐year‐old woman from a consanguineous marriage came to our attention with a 5‐year history of 
movement disorders and behavioral disturbances such as irritability. In her milestones, she was noticed to be 
clumsy and prone to fall. On neurologic examination, she had moderate dystonia in limbs and trunk but 
severe oromandibular dystonia with geste antagoniste (touching lips with index to be able to temporarily 
open her mouth). She had also a blepharospasm forming a Meige‘s syndrome. In addition, there was mild 
parkinsonism with tremor, akinesia and abnormal ocular saccades with retinitis pigmentosa. Brain MRI 
showed the typical eye of the tiger sign (Fig. 1A). She was treated by trihexiphenidyl and botulinum toxin 
injections in the masseter and temporal muscles with respective improvement of the generalized and 
oromandibular dystonia. 
Case 2 
A 24‐year‐old woman from a consanguineous marriage presented early in her life some gait disorders with 
postural instability. By the age of 19, she also started having movement disorders with neurobehavioral 
difficulties (e.g. depression and impulsivity). Her sister had a similar problem. On neurologic examination, 
there was limbs dystonia and severe oromandibular dystonia causing speech and swallowing difficulties. 
This was often complicated by the temporomandibular joint luxation. She also had a parkinsonism. 
Symptoms were very slowly progressive with sometimes dystonic crisis. Brain MRI disclosed the typical eye 
of the tiger sign (Fig. 1B). As a treatment she received trihexiphenidyl and botulinum toxin injections in 
medial pterygoids and subhyoid muscles with a favorable outcome. 
Case 3 
This 19‐year‐old man from a consanguineous marriage consulted for movement disorders and behavioral 
difficulties evolving for 5 years. From the age of 7, he had gait disorder with prone to fall. On examination he 
had generalized dystonia affecting the 4 limbs predominantly upper limbs (left > right) with fixed spastic 
dystonia; cervical dystonia and oromandibular dystonia with speech and swallowing disorder. He also had 
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akinesia, pyramidal signs and retinitis pigmentosa. Blood cooper level was normal. A brain MRI revealed the 
typical eye of the tiger sign (Fig. 1C). He was treated by Baclofen and trihexiphenidyl with a slight 
improvement. 
Case 4 
This 9-year-old girl from a consanguineous marriage came to our attention with a 2‐year history of 
progressive four limbs dystonia. In her milestones, gait was delayed with clumsiness and falls. The 
neurological examination found generalized dystonia affecting limbs, with laterocollis and oromandibular 
dystonia with speech difficulties. In addition, she had pyramidal signs, athetosis and behavioral impairment 
(e.g. hyperfamiliarity). Her brain MRI showed the typical eye of the tiger sign (Fig. 1D). The child‘s DNA 
screening found a c.303_304del: p.S101fs mutation in the PANK2 gene. She was treated by trihexiphenidyl 
with partial improvement. 
DISCUSSION 
We reported 4 cases of classic PKAN retained on clinical data and MRI. Other conditions that may 
exceptionally give the « eye of the tiger sign » would exhibit different clinical phenotypes and thus were not 
discussed in our cases. The mean age of onset was 5.75 years (probably before due to lack of accurate 
data) ; in the literature it is 3.4 years old (5). There is a parental consanguinity in all cases suggesting an 
autosomal recessive pattern. Indeed, PKAN is an autosomal recessive disorder characterized by mutations 
in the gene encoding a mitochondrial pantothenate kinase (PANK2) at locus 20p13-p12.38 [8]. Most PANK2 
mutations are missense variants; especially the c.1561G>A missense mutation is the most common cause of 
PKAN (5). Our case 4 was the only one to benefit from genetic research finding the c.303_304del: p.S101fs 
mutation in PANK2 gene. 
Clinical presentation of our patients was superimposed on that described in literature; Oromandibular 
dystonia was constant and was often complicated by dysarthria and dysphagia. It became generalized 
afterwards. Indeed, in classic PKAN, the majority of patients have oro-bucco-lingual dystonia and dysarthria; 
dystonia is therefore the main symptom; it can be generalized (8). Moreover, we had a parkinsonism in 2 
patients, athetosis and pyramidal syndrome. These phenotypes are rarely described (5). Retinitis 
pigmentosa may occur in two-thirds of patients, associated or not with acanthocytes in blood cells (5,8). Two 
of our patients had retinitis pigmentosa (case1 and case3). Our 4 patients had moderate neuropsychiatric 
disorders with predominant behavioral disorders; in classic PKAN, one-third of patients have 
neuropsychiatric manifestations including behavioral difficulties (5). 
Some affected children often have a history of nonspecific features prior to presentation, including 
clumsiness, dyspraxia, and motor/global neurodevelopmental delay (5). All our patients presented these 
symptoms several years before the onset of disease. 
The progression of PKAN is characterized by cognitive and motor decline; the majority of individuals (85%) 
become wheelchair bound within10-15 years of diagnosis in the classic PKAN (8). Death is usually 
secondary to respiratory infections, cardiorespiratory complications, malnutrition state and, rarely, status 
dystonicus (8). Our patients are currently stabilized under treatment but the follow-up period is insufficient to 
confirm a favorable outcome. It is likely that deterioration would occur, leading to discuss other therapeutic 
methods especially deep brain stimulation. 
The imaging was typical in our 4 patients showing the ―eye-of-the-tiger‖ sign indeed this aspect is the 
characteristic feature on neuroimaging of PKAN (5). It is defined as a central region of signal hyperintensity 
reflecting gliosis and edema, and a surrounding hypointensity caused by iron accumulation in the globus 
pallidus (6). Although pathognomonic of PKAN, this specific MRI sign may be absent in authentic PKAN 
cases especially in the early or late disease stages (2,6). Otherwise, this sign has been reported to occur as 
an imaging phenocopy in other conditions, such as neuroferritinopathy, Wilson‘s disease, mitochondrial 
membrane protein-associated neurodegeneration, multiple system atrophy, and in healthy adults (5,6) ; but 
in those cases, careful assessment often reveals irregular contour and/or lateral displacement of the central 
hyperintensity (4). Hyposignal can also be observed in substantia nigra indicative of iron deposition. 
There is no current specific therapy to stop disease progression; PKAN patients require multidisciplinary 
care. In their study, Cossu et al gave deferiprone to 6 patients with a 4 years follow-up; 5 patients were 
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stabilized suggesting efficacy and safety of deferiprone especially in adult patients at early stage of the 
disease (1). In selected cases of PKAN with drug-resistant dystonia, GPi DBS has been considered with 
results ranging from excellent to very modest improvement (3). 
In PKAN patients who have residual PANK2 activity, the possibility of using high-dose pantothenate therapy 
has been considered (atypical forms) (5). Other symptomatic treatments are trihexiphenidyl, botulinum toxin, 
baclofen…(5). Our patients have all been treated with Trihexyphenidyl 5mg; Baclofen was given in one 
patient; 2 patients received botulinum toxin injections for oro-mandibular dystonia in a timely manner with a 
clear improvement. 
CONCLUSION 
In sum, the data of our patients corroborated those of the classic form of PKAN. Although the genetic 
assessment could only be performed in one case; the diagnosis in the other patients was based on the ―eye-
of-the-tiger‖ sign in an evocative clinical context thus excluding the differential diagnoses mentioned above. 
The perspective in this entity is the development of rational therapeutics targeting the primary biochemical 
anomaly, with compounds that bypass the defective PANK2 enzyme including phantasein, 
phosphopanthethein and coenzyme A. 
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Figure 1: A, B, C and D: axial brain magnetic resonance images with typical eye of the tiger sign in Patients 
1, 2, 3 and 4 respectively. 
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